Every analyst call
Every public market call we’ve tracked, newest first. Filter by instrument, direction, grading status, analyst, firm, or sector — every combination is a shareable link.
Sentiment · Sun Pharmaceutical Industries Limited
Analysts lean bullish
7 analyst stances matching these filters · one per analyst
Trackable
3 · 2 bull / 1 neutral / 0 bear
Long-Horizon
none in window
Commentary
4 · 4 bull / 0 neutral / 0 bear
Bullish 85.7% (6)Neutral 14.3% (1)Bearish 0% (0)
Date range
| Call | Analyst | Instrument | Verdict | Actions |
|---|---|---|---|---|
| “Bullish on Sun Pharma for the next six months, recommending a buy between ₹1,930 and ₹1,970 with a target of ₹2,250 and …” | Pabitro MukherjeeBajaj Broking | Sun Pharmaceutical Industries Ltd | PENDING | |
| “Bullish on pharma; Sun Pharma and Aurobindo Pharma are key large-cap plays. Sun Pharma remains a key stock to watch afte…” | Rahul ShahMotilal Oswal Financial Services | Sun Pharmaceutical Industries Ltd. | HIT | |
| “Emphatically bullish on the Indian pharma sector, believing it is at the start of a multi-decade run and on the cusp of …” | Sudip BandyopadhyayIndependent | Sun Pharma | PENDING | |
| “Regarding Sun Pharma's recent acquisition, Sandip Sabharwal notes a positive initial market reaction and strategic fit, …” | Sandip Sabharwalasksandipsabharwal.com | Sun Pharma | NOT GRADED | |
| “Devarsh Vakil of HDFC Securities holds a positive view on Sun Pharma, highlighting its strategy of deploying strong cash…” | Devarsh VakilHDFC Securities | Sun Pharma | HIT | |
| “Amit Khurana views Sun Pharma's recent acquisition as strategically sound and directionally correct for long-term growth…” | Amit KhuranaDolat Capital | Sun Pharma | PENDING | |
| “Sudip Bandyopadhyay identifies genuine earnings risk for Indian pharma companies with branded drug exposure in the US ma…” | Sudip BandyopadhyayIndependent | Sun Pharma | NOT GRADED | |
| “Amnish Aggarwal is bullish on the pharma sector, noting its recent comeback driven by good numbers and attractive valuat…” | Amnish AggarwalPrabhudas Lilladher Capital | Sun Pharma | HIT |